Stay updated with breaking news from Algert Global. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Stepan (NYSE:SCL – Get Free Report)’s share price gapped up before the market opened on Tuesday following a stronger than expected earnings report. The stock had previously closed at $84.53, but opened at $87.16. Stepan shares last traded at $86.70, with a volume of 17,754 shares. The basic materials company reported $0.64 earnings per share […]
Triumph Capital Management lifted its holdings in Two Harbors Investment Corp. (NYSE:TWO – Free Report) by 4.3% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 21,795 shares of the real estate investment trust’s stock after buying an additional 896 shares during the quarter. Triumph […]
G1 Therapeutics (NASDAQ:GTHX – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at Needham & Company LLC in a research note issued on Wednesday, Benzinga reports. They presently have a $12.00 price target on the stock. Needham & Company LLC’s price objective would suggest a potential upside of 214.96% from […]
Abrdn plc bought a new position in G1 Therapeutics, Inc. (NASDAQ:GTHX – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 423,869 shares of the company’s stock, valued at approximately $1,293,000. abrdn plc owned about 0.82% of G1 Therapeutics at the end […]
Abrdn plc acquired a new stake in G1 Therapeutics, Inc. (NASDAQ:GTHX – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 423,869 shares of the company’s stock, valued at approximately $1,293,000. Several other institutional investors and hedge funds have also recently modified […]